Who owns Immix Biopharma, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of IMMX from SEC Form 13F filings across 137 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 137 institutions disclosed 65.9M shares of Immix Biopharma, Inc. worth $681.1M — about 88.9% of shares outstanding; the largest disclosed holder is Janus Henderson Group Ltd.. Source: SEC Form 13F filings, parsed by EvidInvest.
137
13F holders
$681.1M
value, 2026 filers
88.9%
of shares outstanding (65.9M sh)
43
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of IMMX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Janus Henderson Group Ltd.NEW | 12.1M | $125.6M | 0.1% | 16.3% | new |
| 2 | EVENTIDE ASSET MANAGEMENT, LLC | 5.2M | $54.0M | 0.8% | 7% | +33.3% |
| 3 | Saturn V Capital Management LP | 4.7M | $48.5M | 7.1% | 6.3% | +0.1% |
| 4 | BlackRock, Inc. | 4.5M | $47.2M | 0.0% | 6.1% | +51.8% |
| 5 | STATE STREET CORP | 3.3M | $34.4M | 0.0% | 4.5% | +10.3% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 3.0M | $31.2M | 0.0% | 4.1% | +19.7% |
| 7 | Opaleye Management Inc. | 2.8M | $29.4M | 3.3% | 3.8% | +20.5% |
| 8 | Balyasny Asset Management L.P. | 2.6M | $27.5M | 0.0% | 3.6% | +533.3% |
| 9 | AMERIPRISE FINANCIAL INC | 1.9M | $19.4M | 0.0% | 2.5% | +258.6% |
| 10 | MARSHALL WACE, LLP | 1.9M | $19.3M | 0.0% | 2.5% | +3.3% |
| 11 | FRANKLIN TEMPLETON INC | 1.8M | $14.2M | 0.0% | 2.4% | +84.4% |
| 12 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.7M | $18.2M | 0.0% | 2.4% | +0.6% |
| 13 | WELLINGTON MANAGEMENT GROUP LLP | 1.7M | $17.2M | 0.0% | 2.2% | +12.0% |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 1.4M | $15.0M | 0.0% | 1.9% | +20.0% |
| 15 | ALLIANCEBERNSTEIN L.P. | 1.3M | $13.8M | 0.0% | 1.8% | +3265.9% |
| 16 | Velan Capital Investment Management LP | 1.1M | $11.3M | 10.8% | 1.5% | 0.0% |
| 17 | Bleichroeder LP | 1.0M | $10.4M | 1.0% | 1.3% | 0.0% |
| 18 | CITADEL ADVISORS LLC | 931,361 | $9.7M | 0.0% | 1.3% | +84.0% |
| 19 | MILLENNIUM MANAGEMENT LLC | 865,940 | $9.0M | 0.0% | 1.2% | -58.1% |
| 20 | Aberdeen Group plcNEW | 818,674 | $8.5M | 0.0% | 1.1% | new |
| 21 | ADAGE CAPITAL PARTNERS GP, L.L.C.NEW | 727,272 | $7.6M | 0.0% | 1% | new |
| 22 | VANGUARD PORTFOLIO MANAGEMENT LLC | 607,678 | $6.3M | 0.0% | 0.8% | +114.2% |
| 23 | Blue Owl Capital Holdings LP | 602,047 | $6.3M | 1.1% | 0.8% | +37.6% |
| 24 | NORTHERN TRUST CORP | 521,279 | $5.4M | 0.0% | 0.7% | +24.7% |
| 25 | LGT Fund Management Co Ltd. | 461,159 | $4.8M | 0.2% | 0.6% | +10.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.